Elanco Animal Health Inc. ELAN Proceeds from sale of future revenue, net of transaction costs
Discontinued — last reported Q4 '25
Proceeds from sale of future revenue, net of transaction costs at other companies
Other financials
Where this comes from
Reported directly by Elanco Animal Health Inc. in its filing.
Tagged under the XBRL concept elan:ProceedsFromSaleOfFutureRevenue.
The official record: Elanco Animal Health Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Elanco Animal Health Inc.'s proceeds from sale of future revenue, net of transaction costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Elanco Animal Health Inc.'s proceeds from sale of future revenue, net of transaction costs?
- Elanco Animal Health Inc. (ELAN) reported proceeds from sale of future revenue, net of transaction costs of $72.5M in Q4 2025.
- What does proceeds from sale of future revenue, net of transaction costs mean?
- Cash received today in exchange for a portion of future revenue.
- How do you interpret proceeds from sale of future revenue, net of transaction costs?
- An increase suggests an immediate liquidity boost, but it may signal potential constraints on future cash flows or a need for non-traditional funding.
- How does proceeds from sale of future revenue, net of transaction costs compare across companies?
- Used by companies with strong intellectual property or long-term revenue contracts to access capital.